Tip:
Highlight text to annotate it
X
I'm Shelby Cullinan with today's health news. Alzheimer’s disease has stumped researchers
for decades. Despite a worldwide effort to develop a cure, the progression of Alzheimer’s
remains untreatable. However, new research allowing for early detection may provide the
key to effective treatment. According to a press release issued by the American Osteopathic
Association, researchers from Rowan University School of Osteopathic Medicine have developed
a blood test that is able to detect an early stage of Alzheimer’s disease with unparalleled
accuracy. The researchers believe this development could provide the key not only to early diagnosis
but also to more effective treatment. To conduct their research, the study team focused on
an early stage of Alzheimer’s known as the mild cognitive impairment (MCI) stage. MCI
is the stage between the expected cognition decline of aging and the more serious decline
of dementia. They found autoantibody biomarkers that can identify MCI patients with mild to
moderate Alzheimer’s disease with 100 percent accuracy. For more information, speak to your
doctor today and visit dailyRx.com.